Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Clinical trial NCT02141477 · TERMINATED
Trial details
- NCT number
- NCT02141477
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-06
- Primary completion
- 2017-06-22
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.